Walter Schippinger

Learn More
OBJECTIVE Recombinant granulocyte colony-stimulating factors (G-CSF) have been shown to be effective in reducing the risk of infections associated with antitumour chemotherapy. This report describes(More)
PURPOSE The role of high-dose chemotherapy (HDCT) in metastatic breast cancer remains controversial. Trials with late intensification HDCT have failed to show an advantage in overall survival. This(More)
Purpose To evaluate the impact that pre- and postoperatively administered chemotherapy with cyclophosphamide, methotrexate and fluorouracil (CMF) and postoperative chemotherapy vs. postoperative(More)
641 Background: Trials with late intensification HD have failed to show an advantage in overall survival (OS) for patients with MBC. This trial was initiated to compare up front tandem HD with(More)